{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T08:19:42Z","timestamp":1792484382170,"version":"4.5.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.2215\/cjn.12941213","type":"journal-article","created":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T00:43:07Z","timestamp":1418776987000},"page":"98-109","source":"Crossref","is-referenced-by-count":265,"title":["Recent Changes in Therapeutic Approaches and Association with Outcomes among Patients with Secondary Hyperparathyroidism on Chronic Hemodialysis"],"prefix":"10.2215","volume":"10","author":[{"given":"Francesca","family":"Tentori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian A.","family":"Bieber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Karaboyas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan H.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio E.","family":"Andreucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Fukagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Frimat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Mendelssohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich K.","family":"Port","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald L.","family":"Pisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-15-20230601","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis.","volume":"342","author":"Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"R3-15-20230601","first-page":"289","article-title":"Parathyroidectomy in chronic renal failure.","volume":"55","author":"de Francisco","year":"1985","journal-title":"Q J Med"},{"key":"R4-15-20230601","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease.","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"R5-15-20230601","first-page":"295","article-title":"Hyperparathyroidism and dialysis vintage.","volume":"54","author":"Chertow","year":"2000","journal-title":"Clin Nephrol"},{"key":"R6-15-20230601","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1681\/ASN.V1261242","article-title":"Parathyroidectomy in patients on renal replacement therapy: An epidemiologic study.","volume":"12","author":"Malberti","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R7-15-20230601","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.","volume":"15","author":"Block","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R8-15-20230601","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1681\/ASN.2004040275","article-title":"Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: The USRDS waves 1, 3, and 4 study.","volume":"16","author":"Slinin","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R9-15-20230601","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/j.1523-1755.2005.00185.x","article-title":"Predictors and consequences of altered mineral metabolism: The Dialysis Outcomes and Practice Patterns Study.","volume":"67","author":"Young","year":"2005","journal-title":"Kidney Int"},{"key":"R10-15-20230601","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/sj.ki.5001514","article-title":"Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients.","volume":"70","author":"Kalantar-Zadeh","year":"2006","journal-title":"Kidney Int"},{"key":"R11-15-20230601","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/j.1542-4758.2007.00190.x","article-title":"Association of mineral metabolism factors with all-cause and cardiovascular mortality in hemodialysis patients: The Japan dialysis outcomes and practice patterns study.","volume":"11","author":"Kimata","year":"2007","journal-title":"Hemodial Int"},{"key":"R12-15-20230601","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1053\/j.ajkd.2008.03.020","article-title":"Mortality risk for dialysis patients with different levels of serum calcium, phosphorus, and PTH: The Dialysis Outcomes and Practice Patterns Study (DOPPS).","volume":"52","author":"Tentori","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"R13-15-20230601","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1053\/j.ajkd.2008.07.031","article-title":"Associates of mortality and hospitalization in hemodialysis: Potentially actionable laboratory variables and vascular access.","volume":"53","author":"Lacson","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R14-15-20230601","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1093\/ndt\/gfq219","article-title":"Serum iPTH, calcium and phosphate, and the risk of mortality in a European haemodialysis population.","volume":"26","author":"Floege","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R15-15-20230601","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1001\/jama.2011.308","article-title":"Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: A systematic review and meta-analysis.","volume":"305","author":"Palmer","year":"2011","journal-title":"JAMA"},{"key":"R17-15-20230601","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.ajkd.2010.02.340","article-title":"KDOQI US commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).","volume":"55","author":"Uhlig","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R19-15-20230601","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0272-6386(04)01099-6","article-title":"The Dialysis Outcomes and Practice Patterns Study (DOPPS): Design, data elements, and methodology.","volume":"44","author":"Pisoni","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R20-15-20230601","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1046\/j.1523-1755.2000.07413.x","article-title":"The Dialysis Outcomes and Practice Patterns Study (DOPPS): An international hemodialysis study.","volume":"57","author":"Young","year":"2000","journal-title":"Kidney Int"},{"key":"R21-15-20230601","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/01621459.1996.10476902","article-title":"Identification of causal effects using instrumental variables.","volume":"91","author":"Angrist","year":"1996","journal-title":"J Am Stat Assoc"},{"key":"R23-15-20230601","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhealeco.2007.09.009","article-title":"Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling.","volume":"27","author":"Terza","year":"2008","journal-title":"J Health Econ"},{"key":"R24-15-20230601","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/ndt\/gfn195","article-title":"A practice-related risk score (PRS): A DOPPS-derived aggregate quality index for haemodialysis facilities.","volume":"23","author":"Mendelssohn","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R27-15-20230601","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.2215\/CJN.11501210","article-title":"Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: Associations with changing practice patterns.","volume":"6","author":"Akizawa","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R28-15-20230601","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.ajkd.2010.10.041","article-title":"Trends in parathyroidectomy rates in US hemodialysis patients from 1992 to 2007.","volume":"57","author":"Li","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R29-15-20230601","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.","volume":"16","author":"Foley","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R30-15-20230601","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.","volume":"350","author":"Block","year":"2004","journal-title":"N Engl J Med"},{"key":"R31-15-20230601","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: A randomized, double-blind, multicenter study.","volume":"16","author":"Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R32-15-20230601","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2215\/CJN.05241008","article-title":"Cinacalcet use patterns and effect on laboratory values and other medications in a large dialysis organization, 2004 through 2006.","volume":"4","author":"St Peter","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R33-15-20230601","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2215\/CJN.13081211","article-title":"Prescription patterns and mineral metabolism abnormalities in the cinacalcet era: Results from the MBD-5D study.","volume":"7","author":"Fukagawa","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R34-15-20230601","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1056\/NEJMe1212368","article-title":"Trials in kidney disease\u2014time to EVOLVE.","volume":"367","author":"Perkovic","year":"2012","journal-title":"N Engl J Med"},{"key":"R36-15-20230601","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/1744-9987.12058","article-title":"Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.","volume":"17","author":"Fukagawa","year":"2013","journal-title":"Ther Apher Dial"},{"key":"R37-15-20230601","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/ndt\/gfs598","article-title":"Correlates of parathyroid hormone concentration in hemodialysis patients.","volume":"28","author":"Li","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R38-15-20230601","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1053\/ajkd.2001.29254","article-title":"Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation.","volume":"38","author":"Avram","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R39-15-20230601","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1093\/ndt\/gfp260","article-title":"The association between parathyroid hormone and mortality in dialysis patients is modified by wasting.","volume":"24","author":"Drechsler","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R40-15-20230601","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1681\/ASN.2007050622","article-title":"Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD.","volume":"19","author":"London","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R41-15-20230601","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.2215\/CJN.04260413","article-title":"CKD-mineral and bone disorder and risk of death and cardiovascular hospitalization in patients on hemodialysis.","volume":"8","author":"Block","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R42-15-20230601","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/ndt\/15.9.1310","article-title":"Improving the outcome of dialysis\u2014opinion vs scientific evidence. Report on the Dialysis Opinion Symposium at the ERA-EDTA Congress, 6 September 1999, Madrid.","volume":"15","author":"Ledebo","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R43-15-20230601","doi-asserted-by":"crossref","first-page":"c27","DOI":"10.1159\/000328060","article-title":"Summary of the 5th edition of the Renal Association Clinical Practice Guidelines (2009-2012).","volume":"118","author":"Mactier","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"R44-15-20230601","first-page":"S1","article-title":"Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology.","volume":"17","author":"Jindal","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R45-15-20230601","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1440-1797.2011.01535.x","article-title":"KHA-CARI guideline: Biochemical and haematological targets: Haemoglobin concentrations in patients using erythropoietin-stimulating agents.","volume":"17","author":"McMahon","year":"2012","journal-title":"Nephrology (Carlton"},{"key":"R46-15-20230601","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1111\/j.1440-1797.2006.00508.x","article-title":"The CARI guidelines. Management of bone disease, calcium, phosphate and parathyroid hormone.","volume":"11","author":"Elder","year":"2006","journal-title":"Nephrology (Carlton"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201501000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:51Z","timestamp":1786369551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201501000-00015"}},"subtitle":["The DOPPS Study"],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.12941213","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]}}}